CGNX
Cognex Corporation
CGNX has slightly lower modeled downside risk, despite its lower overall score.
MU
Micron Technology, Inc.
MU has the edge over CGNX overall, supported by stronger valuation and stronger modeled upside.
CGNX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CGNX's revenue, profitability, cash flow and balance sheet are all currently healthy.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
CGNX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 26x | $50.77 | — |
| Current | 35x | $50.77 | — |
| Cheap | 40x | $57.69 | +14% |
| Fair | 55x | $79.70 | +57% |
| Expensive | 79x | $113 | +123% |
Historical ranges are pointers, not guarantees.
CGNX has the edge over MU in the historical PE scenario, which offers more potential upside but is not a forecast.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.
CGNX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CGNX, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
CGNX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.94 | +35% |
| Q3 2026 | $1.44 | +122% |
| Q2 2026 | $1.04 | +44% |
| Q1 2026 | $0.85 | +23% |
| Q4 2025 | $0.68 | +9.7% |
| Q3 2025 | $0.65 | +27% |
| Q2 2025 | $0.72 | +60% |
| Q1 2025 | $0.69 | +21% |
| Q4 2024 | $0.62 | -4.6% |
CGNX earned $1.44 per share over the past year, up 122% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over CGNX on earnings, with more consistent year-over-year improvement.
CGNX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $313.4M | +13% |
| Q2 2026 | $291.3M | +17% |
| Q1 2026 | $268.4M | +24% |
| Q4 2025 | $252.3M | +9.9% |
| Q3 2025 | $276.9M | +18% |
| Q2 2025 | $249.1M | +4.1% |
| Q1 2025 | $216M | +2.5% |
| Q4 2024 | $229.7M | +17% |
CGNX's revenue has grown year over year for nine quarters in a row: $313M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | +11 points |
| Q2 2026 | 29% | +12 points |
| Q1 2026 | 22% | +10 points |
| Q4 2025 | 14% | +0.6 points |
| Q3 2025 | 21% | +7.4 points |
| Q2 2025 | 17% | +1.4 points |
| Q1 2025 | 12% | +5.3 points |
| Q4 2024 | 13% | +7 points |
CGNX's operating margin was 32% last quarter, up 11 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over CGNX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over CGNX on profitability, with a higher operating margin.
CGNX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $103.8M | +21% |
| Q2 2026 | $67.6M | +67% |
| Q1 2026 | $42.3M | +11% |
| Q4 2025 | $72.3M | +47% |
| Q3 2025 | $86M | +66% |
| Q2 2025 | $40.4M | +74% |
| Q1 2025 | $38M | +297% |
| Q4 2024 | $49.3M | +560% |
CGNX has the edge over MU on cash flow, with more consistent year-over-year improvement.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU generated $59B in free cash flow over the past year, more than ten times what it generated the year before.
CGNX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +1M shares |
| 1 year | +1% | +1.7M shares |
| 3 years | -1.3% | -2.3M shares |
| 5 years | -5.2% | -9.3M shares |
| Available history | -2.4% | -4.2M shares |
CGNX has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $6.2M |
| Q1 2026 | $99M |
| Q4 2025 | $25M |
| Q3 2025 | $24M |
| Q2 2025 | — |
| Q1 2025 | $102.2M |
| Q4 2024 | $43.2M |
CGNX spent $130M buying back its own shares over the past year, down 23% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
CGNX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -1.3x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
CGNX has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
CGNX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.1 | Neutral |
| Stochastic | 13.4 | Oversold |
CGNX's weekly RSI is 41 (neutral) and its Stochastic is 13 (oversold).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
CGNX PE vs Technology Sector
| Metric | CGNX | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 28x | 27% above |
| PE % | 8 | 35 | 27 pts below |
CGNX is trading at 35x earnings, a 27% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over CGNX on valuation relative to its sector.
CGNX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.4 | 9.9% below |
| 20 week MA | $60.9 | 17% below |
| 50 week MA | $55.1 | 7.8% below |
| 100 week MA | $45.6 | 11% above |
| 200 week MA | $44.9 | 13% above |
CGNX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 13% above its 200-week average.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over CGNX on trend strength, trading above more of its moving averages.
CGNX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.2 | $80.7 | +44% |
| 2021 | $80.7 | $77.6 | -3.9% |
| 2022 | $77.6 | $47.4 | -39% |
| 2023 | $47.4 | $41.7 | -12% |
| 2024 | $41.7 | $36.0 | -14% |
| 2025 | $36.0 | $36.6 | +1.4% |
| 2026 YTD | $36.6 | $50.8 | +39% |
CGNX is up 39% so far in 2026, after finishing lower in four of the previous six years.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over CGNX on returns for 2026, with the stronger performance.